Table 2.
Group differences in body composition and inflammatory markers
| CAH (n = 27) | Controls (n = 35) | p | |
|---|---|---|---|
| Body composition | |||
| WHtR | 0.56±0.11 | 0.46±0.06 | 0.002 |
| BMI z | 1.61±0.86 | 0.80±0.95 | 0.004 |
| Proportional VAT | 0.07±0.03 | 0.05±0.03 | 0.029 |
| Proportional SAT | 0.25±0.14 | 0.35±0.13 | 0.01 |
| Inflammatory markers | |||
| MCP-1, pg/mL | 93±37 | 62±23 | 0.003 |
| Leptin, pg/mL | 14,627±11,231 | 7,182±7,119 | 0.012 |
| TNF-α, pg/mL | 3.70±1.31 | 3.30±1.56 | 0.4 |
| Resistin, µg/mL | 0.03±0.02 | 0.03±0.02 | >0.9 |
| IL-6, pg/mL | 1.78±1.81 | 2.28±1.98 | 0.4 |
| Adiponectin, µg/mL | 3.69±1.01 | 3.57±1.01 | 0.7 |
| PAI-1, µg/mL | 0.03±0.01 | 0.03±0.01 | 0.4 |
Mean ± SD.
CAH, congenital adrenal hyperplasia; WHtR, waist-to-height ratio; BMI z, body mass index z-score; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; MCP-1, monocyte chemoattractant protein-1; TNF-α, tumor necrosis factor-alpha; IL-6, interleukin-6; PAI-1, plasminogen activator inhibitor-1.